1
|
Lee HN, Park SJ, Cho Y, Lee S. SUPERA stent placement for salvaging early recurrent arteriovenous graft thrombosis after percutaneous transluminal angioplasty: A single-center study. J Vasc Access 2024; 25:1285-1292. [PMID: 36932956 DOI: 10.1177/11297298231160196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/19/2023] Open
Abstract
BACKGROUND The aim of this study was to evaluate the patency of the helical interwoven SUPERA stent for salvaging prosthetic arteriovenous (AV) grafts with rapidly recurrent thrombotic occlusion developed within a short time period after successful percutaneous transluminal angioplasty. METHODS From December 2019 to September 2021, the data of 20 patients with AV graft who had the SUPERA stent inserted satisfying the following conditions were consecutively collected. (1) More than 1 year has passed since the AV access operation; (2) Thrombotic re-occlusion of AV graft occurred within 3 months after previous successful endovascular treatment; (3) Residual stenosis is greater than 30% after full effacement of balloon angioplasty in the primary lesion. Post-interventional target lesion primary patency (TLPP), access circuit primary patency (ACPP), and secondary patency (SP) were calculated. RESULTS Primary lesions of early recurrent arteriovenous graft thrombosis were found in 13 patients with graft-vein anastomosis, six patients with intra-graft stenosis, and one patient with outflow vein complications. The lesions showed residual stenosis in 47.4% (interquartile range: 44.1%-55.3%) of patients despite full-effacement balloon angioplasty. Clinical success was achieved in all patients with full-expansion of the stents at the 1-month follow-up. The TLPP was 70.7% and 32% at 6 and 12 months, respectively, and ACPP was 47.5% and 6.8% at 6 and 12 months, respectively. The SP was 76.1% and 57.1% at 6 and 12 months, respectively. No cannulation complications occurred in the six patients with installation inside the graft. No hemodialysis or stent fracture occurred in any patient during the follow-up period. CONCLUSIONS The SUPERA stent may have a role in salvaging AV grafts with early recurrent thrombosis due to its greater radial force and its conformability and can be useful in treating stenosis involving the elbow or axilla, with fair patency and low complication rates.
Collapse
Affiliation(s)
- Hyoung Nam Lee
- Department of Radiology, Soonchunhyang University College of Medicine, Cheonan Hospital, Cheonan-si, South Korea
| | - Sung-Joon Park
- Department of Radiology, Korea University Ansan Hospital, Ansan-si, Gyeonggi-do, South Korea
| | - Youngjong Cho
- Department of Radiology, University of Ulsan College of Medicine, Gangneung Asan Hospital, Gangneung-si, Gangwon-do, South Korea
| | - Sangjoon Lee
- Vascular Center, The Eutteum Orthopedic Surgery Hospital, Paju-si, South Korea
| |
Collapse
|
2
|
Ng O, Thomas S, Gunasekera S, Varcoe R, Barber T. Identifying problematic arteriovenous fistula with CFD-derived resistance: An exploratory study. J Biomech 2024; 171:112203. [PMID: 38908106 DOI: 10.1016/j.jbiomech.2024.112203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2023] [Revised: 05/23/2024] [Accepted: 06/19/2024] [Indexed: 06/24/2024]
Abstract
Arteriovenous fistula (AVF) is the optimal form of vascular access for most haemodialysis dependant patients; however, it is prone to the formation of stenoses that compromise utility and longevity. Whilst there are many factors influencing the development of these stenoses, pathological flow-related phenomena may also incite the formation of intimal hyperplasia, and hence a stenosis. Repeated CFD-derived resistance was calculated for six patient who had a radiocephalic AVF, treated with an interwoven nitinol stent around the juxta-anastomotic region to address access dysfunction. A three-dimensional freehand ultrasound system was used to obtain patient-specific flow profiles and geometries, before performing CFD simulations to replicate the flow phenomena in the AVF, which enabled the calculation of CFD-derived resistance. We presented six patient cases who were examined before and after treatment and our results showed a 77% decrease in resistance, recorded after a surgical intervention to address access dysfunction. Problematic AVFs were found to have high resistance, particularly in the venous segment. AVFs with no reported clinical problems, and clinical patency, had low resistance in the venous segment. There did not appear to be any relationship with clinical problems/patency and resistance values in the arterial segment. Identifying changes in resistance along the circuit allowed stenoses to be identified, independent to that determined using standard sonographic criteria. Our exploratory study reveals thatCFD-derived resistance is a promising metric that allows for non-invasive identification of diseased AVFs. The pipeline analysis enabled regular surveillance of AVF to be studied to aid with surgical planning and outcome, further exhibiting its clinical utility.
Collapse
Affiliation(s)
- Olivia Ng
- School of Mechanical and Manufacturing Engineering, University of New South Wales, Sydney NSW 2052, Australia.
| | - Shannon Thomas
- School of Medicine, University of New South Wales, Sydney NSW 2052, Australia; Prince of Wales Hospital, Sydney NSW 2031, Australia
| | - Sanjiv Gunasekera
- School of Mechanical and Manufacturing Engineering, University of New South Wales, Sydney NSW 2052, Australia
| | - Ramon Varcoe
- School of Medicine, University of New South Wales, Sydney NSW 2052, Australia; Prince of Wales Hospital, Sydney NSW 2031, Australia
| | - Tracie Barber
- School of Mechanical and Manufacturing Engineering, University of New South Wales, Sydney NSW 2052, Australia
| |
Collapse
|
3
|
Gunasekera S, de Silva C, Ng O, Thomas S, Varcoe R, Barber T. Stenosis to stented: decrease in flow disturbances following stent implantation of a diseased arteriovenous fistula. Biomech Model Mechanobiol 2024; 23:453-468. [PMID: 38063956 DOI: 10.1007/s10237-023-01784-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2023] [Accepted: 10/14/2023] [Indexed: 03/26/2024]
Abstract
The arteriovenous fistula (AVF) is commonly faced with stenosis at the juxta-anastomotic (JXA) region of the vein. Implantation of a flexible nitinol stent across the stenosed JXA has led to the retention of functioning AVFs leading to the resulting AVF geometry being distinctly altered, thereby affecting the haemodynamic environment within it. In this study, large eddy simulations of the flow field within a patient-specific AVF geometry before and after stent implantation were conducted to detail the change in flow features. Although the diseased AVF had much lower flow rates, adverse flow features, such as recirculation zones and swirling flow at the anastomosis, and jet flow at the stenosis site were present. Larger velocity fluctuations (leading to higher turbulent kinetic energy) stemming from these flow features were apparent in the diseased AVF compared to the stented AVF. The unsteadiness at the stenosis created large regions of wall shear stress (WSS) fluctuations downstream of the stenosis site that were not as apparent in the stented AVF geometry. The larger pressure drop across the diseased vein, compared to the stented vein, was primarily caused by the constriction at the stenosis, potentially causing the lower flow rate. Furthermore, the WSS fluctuations in the diseased AVF could lead to further disease progression downstream of the stenosis. The change in bulk flow unsteadiness, pressure drop, and WSS behaviour confirms that the haemodynamic environment of the diseased AVF has substantially improved following the flexible stent implantation.
Collapse
Affiliation(s)
- Sanjiv Gunasekera
- School of Mechanical and Manufacturing Engineering, The University of New South Wales, Sydney, NSW, 2052, Australia.
| | - Charitha de Silva
- School of Mechanical and Manufacturing Engineering, The University of New South Wales, Sydney, NSW, 2052, Australia
| | - Olivia Ng
- School of Mechanical and Manufacturing Engineering, The University of New South Wales, Sydney, NSW, 2052, Australia
| | - Shannon Thomas
- Department of Vascular Surgery, Prince of Wales Hospital, Randwick, NSW, 2031, Australia
| | - Ramon Varcoe
- Department of Vascular Surgery, Prince of Wales Hospital, Randwick, NSW, 2031, Australia
| | - Tracie Barber
- School of Mechanical and Manufacturing Engineering, The University of New South Wales, Sydney, NSW, 2052, Australia
| |
Collapse
|
4
|
Chua CH, Lu MJ, Chao HH. Treatment of intragraft stenosis in hemodialysis grafts with Supera stents: A retrospective study. J Vasc Access 2024; 25:125-131. [PMID: 35634984 DOI: 10.1177/11297298221077605] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2024] Open
Abstract
PURPOSE To report the patency rates after implantation of an interwoven nitinol stent to salvage failing arteriovenous grafts (AVGs) caused by intragraft stenoses. METHODS Between May 2018 and May 2020, 21 Supera stents were placed in 20 patients (18 women; mean age: 79.9 years) who had a failing AVG due to repeat intragraft stenoses. Recurrent AVG dysfunction with same intragraft stenosis within 3 months after first time angioplasty was a criterion for stenting. Those with concurrent treatment for other lesions were excluded. RESULTS The technical success rate was 100%. Intragraft stenoses were treated at a median of 19.7 (interquartile range: 6-36) months after graft creation. Access circuit primary patency rates after stent placement were 84% and 35% at 6 and 12 months, respectively. Access circuit secondary patency rates were 100% at 6 and 12 months and 89% at 18 months. Only one patient presented with graft failure due to proximal drainage vein occlusion. The target lesion patency rates were 100% at 6 months and 75% at 12 months. The rate of reintervention for intragraft lesion was 0.15 procedures per year. Stent distortion did not occur under regular cannulation. CONCLUSION The interwoven nitinol stent is a promising treatment for failing AVGs with recurrent intragraft stenoses. The 1-year access circuit primary, secondary, and target lesion patency rates were acceptable, with a low reintervention rate. Stent fracture does not occur in areas of needle puncture.
Collapse
Affiliation(s)
- Chai-Hock Chua
- Division of Cardiovascular Surgery, Department of Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Taipei
| | - Ming-Jen Lu
- Division of Cardiovascular Surgery, Department of Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Taipei
| | - Hung-Hsing Chao
- Division of Cardiovascular Surgery, Department of Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Taipei
| |
Collapse
|
5
|
Shaikh A, Albalas A, Desiraju B, Dwyer A, Haddad N, Almehmi A. The role of stents in hemodialysis vascular access. J Vasc Access 2023; 24:107-116. [PMID: 33993804 PMCID: PMC10896277 DOI: 10.1177/11297298211015069] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023] Open
Abstract
Vascular access is the Achilles' heel of dialysis therapy among patient with end stage kidney disease. The development of neointimal hyperplasia and subsequent stenosis is common in vascular access and is associated with significant morbidity. Percutaneous transluminal angioplasty using balloon inflation was the standard therapy of these lesions. However, the balloon-based approaches were associated with poor vascular access patency rate necessitating new inventions. It is within this context that different types of stents were developed in order to improve the overall dialysis vascular access functionality. In this article, we review the available literature regarding the use of stents in treating dialysis vascular access stenotic lesions. Further, we review the major clinical trials of stent use in different anatomic locations and in different clinical scenarios.
Collapse
Affiliation(s)
- Aisha Shaikh
- Department of Medicine, James J. Peters VA Medical Center, Bronx, NY, USA
| | - Alian Albalas
- Department of Biology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Brinda Desiraju
- Department of Medicine, SUNY Downstate School of Medicine, Brooklyn, NY, USA
| | - Amy Dwyer
- Department of Medicine, University of Louisville, Louisville, KY, USA
| | - Nabil Haddad
- Department of Medicine, The Ohio State University Medical Center, Columbus, OH, USA
| | - Ammar Almehmi
- Department of Medicine and Radiology, University of Alabama at Birmingham, Birmingham, AL, USA
| |
Collapse
|
6
|
Gunawardena T, Ridgway D. Swing segment stenosis: An unresolved challenge. Semin Dial 2022; 35:307-316. [PMID: 35475553 DOI: 10.1111/sdi.13086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2021] [Revised: 03/08/2022] [Accepted: 04/05/2022] [Indexed: 11/29/2022]
Abstract
The native arteriovenous fistula is considered the gold standard among all dialysis access options. Compared with alternatives such as grafts and central venous catheters, their use is associated with a lower risk of infective and thrombotic complications. This leads to better patient outcomes and reduced healthcare-associated costs. Recognizing these advantages, there is a global drive to increase the creation and use of such fistulas in hemodialysis patients. Swing segment stenosis is a common problem encountered with the creation and use of these fistulas that can hurt their maturation and longevity. A "swing segment" in an arteriovenous fistula is defined as a segment of vein that pursues a sharp, curved course. Due to poorly understood reasons, these swing segments tend to develop stenotic lesions that are extremely challenging to treat. This review aims to provide an overview of the pathophysiology, incidence, management, and prevention of these swing segment lesions. We believe that such knowledge will be useful for clinicians who deal with dialysis access creation and maintenance.
Collapse
Affiliation(s)
- Thilina Gunawardena
- Fellow in Renal Transplant and Vascular Access Surgery, Royal Liverpool University Hospital, Liverpool, UK
| | - Dan Ridgway
- Consultant Renal Transplant and Vascular Access Surgeon, Royal Liverpool University Hospital, Liverpool, UK
| |
Collapse
|
7
|
Thomas SD, Peden S, Katib N, Crowe P, Barber T, Varcoe RL. Long-term Results of Interwoven Nitinol Stents to Treat the Radiocephalic Anastomotic Arteriovenous Fistula Stenosis. J Endovasc Ther 2022; 30:176-184. [PMID: 35098757 DOI: 10.1177/15266028221075230] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Introduction: Juxta-anastomotic stenosis (JXAS) is a common problem afflicting the arteriovenous fistula (AVF). This study aimed to evaluate the safety and long-term efficacy of an interwoven nitinol stent (Supera, Abbott Vascular, Santa Clara, CA, USA) in the treatment of radiocephalic AVF JXAS. Methods: A single-center, retrospective, observational study was conducted of patients with failing AVF due to JXAS treated with an interwoven nitinol stent. End points included JXAS target lesion primary patency, access circuit primary patency, assisted access circuit primary patency, and endovascular intervention rate (EIR). Results: Sixty patients were treated with a Supera stent in the JXAS between February 2014 and March 2020. One patient was excluded (AVF used for illicit drug use), leaving 59 patients (67.8% male, mean age 66.9 ± 11.4 years [range: 40–84]) with typical medical comorbidities. Overall, 45.8% of patients had previous AVF intervention. The stent was inserted with a 100% technical success rate with a mean follow-up of 729.6 ± 456.0 days (range: 5–2182 days). Juxta-anastomotic stenosis target lesion primary patency was 68.2 ± 6.6%, 53.3 ± 7.5%, and 46.2 ± 8.1% at 12, 24, and 36 months, respectively. The EIR was .64 (0–3.29) procedures/patient/year, after which the assisted access circuit primary patency rate was 94.3 ± 3.2% at 12, 24, and 36 month time points. Three thrombosed circuits occurred which were all successfully salvaged with no difference in patency by indication for procedure and no AVFs lost/abandoned out to 3 years. Avoidance of stent post-dilatation and the presence of stent mal-apposition were associated with improved primary patency, and reduced EIR, which may suggest an importance in vessel preparation prior to stent implantation. Conclusion: Interwoven nitinol stent treatment of the failing AVF with JXAS results in promising 3 year JXAS patency, with a low rate of endovascular re-intervention for those circuits developing restenosis. All AVFs were maintained over 3 years, demonstrating this treatment allows for long-term radiocephalic AVF vascular access.
Collapse
Affiliation(s)
- Shannon D. Thomas
- Department of Vascular Surgery, Prince of Wales Private Hospital, Sydney, NSW, Australia
- Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia
- The Vascular Institute, Prince of Wales Private Hospital, Sydney, NSW, Australia
| | - Samantha Peden
- Department of Vascular Surgery, Prince of Wales Private Hospital, Sydney, NSW, Australia
| | - Nedal Katib
- Department of Vascular Surgery, Prince of Wales Private Hospital, Sydney, NSW, Australia
- Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia
- The Vascular Institute, Prince of Wales Private Hospital, Sydney, NSW, Australia
| | - Phillip Crowe
- Department of Surgery, Prince of Wales Private Hospital, Sydney, NSW, Australia
| | - Tracie Barber
- Faculty of Mechanical Engineering, UNSW Sydney, Sydney, NSW, Australia
| | - Ramon L. Varcoe
- Department of Vascular Surgery, Prince of Wales Private Hospital, Sydney, NSW, Australia
- Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia
- The Vascular Institute, Prince of Wales Private Hospital, Sydney, NSW, Australia
| |
Collapse
|
8
|
Arteriovenous Fistula Formation with Adjuvant Endovascular Maturation. J Vasc Surg 2021; 75:641-650.e2. [PMID: 34506894 DOI: 10.1016/j.jvs.2021.08.072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2021] [Accepted: 08/16/2021] [Indexed: 11/23/2022]
Abstract
INTRODUCTION The clinical utility of the native arteriovenous fistula (AVF) is limited by a prolonged time to maturation, low overall maturation rate, and subsequent abandonment. Endovascular intervention is increasingly accepted as first line therapy to treat AVF stenosis. The objective of this study was to evaluate AVF formation outcomes when early endovascular intervention was selectively performed to bring about timely AVF maturation. METHODS A retrospective study (February 2014- February 2020) was performed on 82 AVF consecutive patients (mean age 62.5±13.5 (17-83); 58 male (70.7%)) with end-stage renal failure who had Vascular Access (VA) construction at a single institution. Four year AVF patency, vascular diameters, haemodialysis parameters, re-intervention rate, and mortality were analysed. RESULTS Radiocephalic AVF was the most common fistula constructed (71 patients; 88.6%). Post formation evaluation (46.2+/-56.0 days (5-343)) revealed 33 (40.2%) immature AVFs. Subsequently, 19 patients underwent endovascular procedures consisting of angioplasty/stenting of the juxta-anastomosis, cannulation and/or outflow segments to bring about timely maturation of the AVF. Hence 93.9% of AVFs had reached functional patency (maturation) by 6 months post formation, with a mean time to maturation of 67.8 +/- 65.9 (5-320) days. After reaching maturation, Primary Access Functional Patency was 82 +/- 4.3 % at 6 months, 58+/- 5.5% at 12 months and 34 +/- 6.8% at 48 months. Primary Assisted Access Functional Patency was 95 +/- 2.4% at 6 months, 90 +/-3.3 % at 12 months and 83 % +/- 4.7 % at 48 months. 121 endovascular interventions were performed to maintain patency, equating to an endovascular reintervention rate of .37 procedures/patient year. Mean arterial, venous and brachial flow rates did not change significantly after maturation with a mean fistula (primary assisted functional patency) survival time of 5.9 +/- 0.26 (5.33- 6.36) years from maturation. Only 12 thromboses occurred after the first post formation follow up review, which were all salvaged using endovascular techniques leading to 100% Total secondary functional patency at 4 years. 5 year estimated all-cause mortality was 45.6 +/-12.7%. CONCLUSION Arteriovenous fistula maturation rate and time to maturation can be improved when early endovascular intervention is selectively performed post formation. This allows for near universal maturation where, once matured, the use of ongoing endovascular re-intervention allows for a low re-intervention rate and long term patency providing for reliable long term renal vascular access.
Collapse
|
9
|
Bradette S, Méthot M, Gahide G, Létourneau-Montminy M, Lalonde C, Côté F, Garneau G, Béland M. Endovascular Venous Outflow Redirection in Failing Arteriovenous Hemodialysis Access Using a Combination of Covered and Interwoven Nitinol Stents. J Vasc Interv Radiol 2020; 31:1911-1914. [PMID: 33129436 DOI: 10.1016/j.jvir.2020.07.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2020] [Revised: 07/22/2020] [Accepted: 07/23/2020] [Indexed: 11/30/2022] Open
Affiliation(s)
- Simon Bradette
- Department of Radiology, Centre Hospitalier Universitaire de Québec, 10 Rue de l'Espinay, Québec, QC G1L 3L5, Canada
| | - Mireille Méthot
- Department of Surgery, Centre Hospitalier Universitaire de Québec, 10 Rue de l'Espinay, Québec, QC G1L 3L5, Canada
| | - Gérald Gahide
- Departments of Radiology, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada
| | - Myriam Létourneau-Montminy
- Department of Surgery, Centre Hospitalier Universitaire de Québec, 10 Rue de l'Espinay, Québec, QC G1L 3L5, Canada
| | - Catherine Lalonde
- Department of Radiology, Centre Hospitalier Universitaire de Québec, 10 Rue de l'Espinay, Québec, QC G1L 3L5, Canada
| | - François Côté
- Department of Radiology, Centre Hospitalier Universitaire de Québec, 10 Rue de l'Espinay, Québec, QC G1L 3L5, Canada
| | - Guillaume Garneau
- Department of Radiology, Centre Hospitalier Universitaire de Québec, 10 Rue de l'Espinay, Québec, QC G1L 3L5, Canada
| | - Mathieu Béland
- Department of Radiology, Centre Hospitalier Universitaire de Québec, 10 Rue de l'Espinay, Québec, QC G1L 3L5, Canada
| |
Collapse
|
10
|
Carroll JE, Colley ES, Thomas SD, Varcoe RL, Simmons A, Barber TJ. Tracking geometric and hemodynamic alterations of an arteriovenous fistula through patient-specific modelling. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE 2020; 186:105203. [PMID: 31765935 DOI: 10.1016/j.cmpb.2019.105203] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/28/2019] [Revised: 11/10/2019] [Accepted: 11/11/2019] [Indexed: 06/10/2023]
Abstract
BACKGROUND AND OBJECTIVE The use of patient-specific CFD modelling for arteriovenous fistulae (AVF) has shown great clinical potential for improving surveillance, yet the use of imaging modes such as MRI and CT for the 3D geometry acquisition presents high costs and exposure risks, preventing regular use. We have developed an ultrasound based procedure to bypass these limitations. METHODS A scanning procedure and processing pipeline was developed specifically for CFD modelling of AVFs, using a freehand ultrasound setup combining B-mode scanning with 3D probe motion tracking. The scanning procedure involves sweeping along the vasculature to create a high density stack of B-mode frames containing the lumen geometry. This stack is converted into a continuous volume and transient flow waveforms are recorded at the boundaries, synchronised with ECG and automatically digitised, forming realistic boundary conditions for the CFD models. This is demonstrated on a diseased patient-specific AVF. RESULTS The three scans obtained using this procedure varied in geometry and flow behaviour, with regions of disease located in the first two scans. The outcome of the second procedure seen in the third scan indicated successful restoration with no sites of disease and higher flow. The models gave insight into the lumenal changes in diameter for both the artery and vein segments, as well as characterising hemodynamic behaviours in both the diseased and restored states. Vascular segment resistances obtained from the CFD models indicate a significant reduction once disease was removed, resulting in much higher flows enabling the patient to resume dialysis. CONCLUSION The methodology described in this study allowed for a multifaceted analysis and high level tracking in terms of both geometry and flow behaviours for a patient case, demonstrating significant clinical utility and practicality, as well as enabling further research into vascular disease progression in AVFs through longitudinal analysis.
Collapse
Affiliation(s)
- John E Carroll
- School of Mechanical and Manufacturing Engineering, University of New South Wales, Sydney, 2052, NSW, Australia
| | - Eamonn S Colley
- School of Mechanical and Manufacturing Engineering, University of New South Wales, Sydney, 2052, NSW, Australia
| | - Shannon D Thomas
- Prince of Wales Hospital, Sydney, 2031, NSW, Australia; School of Medicine, University of New South Wales, Sydney, 2052, NSW, Australia
| | - Ramon L Varcoe
- Prince of Wales Hospital, Sydney, 2031, NSW, Australia; School of Medicine, University of New South Wales, Sydney, 2052, NSW, Australia
| | - Anne Simmons
- School of Mechanical and Manufacturing Engineering, University of New South Wales, Sydney, 2052, NSW, Australia
| | - Tracie J Barber
- School of Mechanical and Manufacturing Engineering, University of New South Wales, Sydney, 2052, NSW, Australia.
| |
Collapse
|
11
|
Quaretti P, Cionfoli N, Moramarco LP, Leati G, Corti R. Durability of Stent-Grafts for Radiocephalic Fistulas. J Endovasc Ther 2019; 26:887. [PMID: 31736426 DOI: 10.1177/1526602819875486] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Pietro Quaretti
- Unit of Interventional Radiology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
| | - Nicola Cionfoli
- Unit of Interventional Radiology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
| | | | - Giovanni Leati
- Radiology Department, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
| | - Riccardo Corti
- Radiology Department, IRCCS Policlinico San Matteo Foundation, Pavia, Italy
| |
Collapse
|